CEO, CAO of Institute of Science Tokyo Vow to Help Japanese Society Adapt Times; Executives Hope for Interdisciplinary Collaboration

The Institute of Science Tokyo’s Naoto Ohtake, president and chief executive officer of the Institute of Science Tokyo, right, and Yujiro Tanaka, president and chief academic officer, are seen at a press conference in Tokyo on Tuesday.
17:53 JST, October 1, 2024
Executives of the newly opened Institute of Science Tokyo held a press conference on Tuesday at the university’s Ookayama Campus.
“Our former universities have merged to respond better to changes in society and to pave the way for a better future. We want to direct the power of science, which progresses rapidly, back toward society and make a university that transforms society,” said Naoto Ohtake, president and chief executive officer of the university and former professor at the Tokyo Institute of Technology.
Yujiro Tanaka, president and chief academic officer of the new university and former president of Tokyo Medical and Dental University, said: “Innovations made through combining medical and dental studies with science and engineering studies are necessary to solve societal problems. By encouraging the circulation of knowledge from different academic fields, I hope researchers will uncover new value and contribute to society together.”
Top Articles in Society
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
15 Measles Patients Confirmed in Tokyo in Past 6 Days; 1 May Have Come into Contact with Many in Shibuya
-
Bus Carrying 40 Passengers Catches Fire on Chuo Expressway; All Evacuate Safely
-
Ibaraki Pref.’s 1st Foreign Bus Driver Hired in Tsukuba
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

